Atrial fibrillation, liver disease, antithrombotics and risk of cerebrovascular events: A population-based cohort study.


BACKGROUND Whether patients with atrial fibrillation (AF) and liver disease are also prone to cerebrovascular events and respond similarly favorably to antithrombotic therapy remains under-investigated. METHODS Patients ≥18years with newly-diagnosed AF in the period 2005 to 2009 were scrutinized from the "Longitudinal Health Insurance Database 2005" (1… (More)
DOI: 10.1016/j.ijcard.2016.08.297

10 Figures and Tables


  • Presentations referencing similar topics